CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 260 filers reported holding CONMED CORP in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $211 | +205.8% | 2,033 | +158.7% | 0.00% | – |
Q4 2022 | $69 | -99.9% | 786 | 0.0% | 0.00% | – |
Q3 2022 | $63,000 | -16.0% | 786 | 0.0% | 0.00% | – |
Q2 2022 | $75,000 | -98.9% | 786 | -98.3% | 0.00% | -100.0% |
Q1 2022 | $6,925,000 | -14.0% | 46,620 | -17.9% | 0.01% | -11.1% |
Q4 2021 | $8,052,000 | +17031.9% | 56,802 | +15634.6% | 0.01% | – |
Q3 2021 | $47,000 | -89.7% | 361 | -89.6% | 0.00% | -100.0% |
Q1 2021 | $455,000 | -49.1% | 3,485 | -56.4% | 0.00% | 0.0% |
Q4 2020 | $894,000 | +3338.5% | 7,991 | +2299.7% | 0.00% | – |
Q3 2020 | $26,000 | -40.9% | 333 | -45.9% | 0.00% | – |
Q2 2020 | $44,000 | -96.4% | 615 | -97.2% | 0.00% | -100.0% |
Q1 2020 | $1,238,000 | +33.8% | 21,630 | +161.2% | 0.00% | +100.0% |
Q4 2019 | $925,000 | +44.5% | 8,280 | +24.2% | 0.00% | 0.0% |
Q3 2019 | $640,000 | +63.3% | 6,665 | +45.2% | 0.00% | 0.0% |
Q2 2019 | $392,000 | – | 4,591 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthCor Management, L.P. | 27,500 | $2,437,600 | 2.23% |
Ranger Investment Management | 316,318 | $28,038,428 | 2.08% |
Lighthouse Investment Partners, LLC | 142,100 | $12,595,744 | 1.39% |
Lighthouse Investment Partners, LLC | 139,200 | $12,338,688 | 1.36% |
EARNEST PARTNERS LLC | 2,402,352 | $212,944,481 | 1.30% |
Lighthouse Investment Partners, LLC | 108,200 | $9,590,848 | 1.06% |
MOODY ALDRICH PARTNERS LLC | 51,885 | $4,599,086 | 0.93% |
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID | 125,435 | $11,118,558 | 0.81% |
Champlain Investment Partners, LLC | 1,275,910 | $113,096,662 | 0.72% |
EPIQ PARTNERS, LLC | 10,463 | $927,440 | 0.62% |